David Gozal1, Leila Kheirandish-Gozal. 1. Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA. david.gozal@louisville.edu
Abstract
PURPOSE OF REVIEW: This review examines in detail progress made regarding our understanding of the presence and pathophysiology of cognitive and behavioral morbidities among children with sleep disorders in general. Particular focus is given to pediatric obstructive sleep apnea. RECENT FINDINGS: In recent years, increased awareness of the morbid consequences of respiratory sleep disturbances in children has emerged. Evidence suggesting a causal association of intermittent hypoxia and sleep fragmentation with alterations in memory, attention, and intelligence has accumulated. Research has also identified a link between sleep disorders, and problematic and hyperactive behaviors and mood disturbances. Furthermore, there is considerable inter-individual variability in the presence and magnitude of neurobehavioral morbidity at any given level of disease severity. This further suggests that, in addition to the disease per se, both genetic (individual susceptibility) and environmental modifiers play a role in determining morbidity. SUMMARY: A more individually tailored approach to detecting morbidity associated with sleep disorders in children, employing biomarkers and gene-related single nucleotide polymorphisms, may ultimately be required to allow more rational prioritization of treatment.
PURPOSE OF REVIEW: This review examines in detail progress made regarding our understanding of the presence and pathophysiology of cognitive and behavioral morbidities among children with sleep disorders in general. Particular focus is given to pediatric obstructive sleep apnea. RECENT FINDINGS: In recent years, increased awareness of the morbid consequences of respiratory sleep disturbances in children has emerged. Evidence suggesting a causal association of intermittent hypoxia and sleep fragmentation with alterations in memory, attention, and intelligence has accumulated. Research has also identified a link between sleep disorders, and problematic and hyperactive behaviors and mood disturbances. Furthermore, there is considerable inter-individual variability in the presence and magnitude of neurobehavioral morbidity at any given level of disease severity. This further suggests that, in addition to the disease per se, both genetic (individual susceptibility) and environmental modifiers play a role in determining morbidity. SUMMARY: A more individually tailored approach to detecting morbidity associated with sleep disorders in children, employing biomarkers and gene-related single nucleotide polymorphisms, may ultimately be required to allow more rational prioritization of treatment.
Authors: Gulnur Com; John L Carroll; Xinyu Tang; Maria S Melguizo; Charles Bower; Supriya Jambhekar Journal: J Clin Sleep Med Date: 2015-04-15 Impact factor: 4.062
Authors: Sharon A McGrath-Morrow; Timothy Ryan; Brian M McGinley; Sande O Okelo; Laura M Sterni; J Michael Collaco Journal: Pediatr Pulmonol Date: 2011-08-03
Authors: Cydni N Williams; Mary E Hartman; Kristin P Guilliams; Rejean M Guerriero; Juan A Piantino; Christopher C Bosworth; Skyler S Leonard; Kathryn Bradbury; Amanda Wagner; Trevor A Hall Journal: Curr Treat Options Neurol Date: 2019-09-27 Impact factor: 3.598